Clinical Trial Update: TTAX03 for the Treatment of Lumbosacral Facet Joint Pain [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of TTAX03 for facet joint pain has been withdrawn from the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Facet Joint Pain

Drugs mentioned

• TTAX03

Snippet

Sponsor: BioTissue Holdings, Inc | Conditions: Facet Joint Pain | Phase 1 | Status: WITHDRAWN